» Articles » PMID: 34834414

A Sneak-Peek into the Physician's Brain: A Retrospective Machine Learning-Driven Investigation of Decision-Making in TAVR Versus SAVR for Young High-Risk Patients with Severe Symptomatic Aortic Stenosis

Abstract

Transcatheter aortic valve replacement (TAVR) has rapidly become a viable alternative to the conventional isolated surgical aortic valve replacement (iSAVR) for treating severe symptomatic aortic stenosis. However, data on younger patients is scarce and a gap exists between data-based recommendations and the clinical use of TAVR. In our study, we utilized a machine learning (ML) driven approach to model the complex decision-making process of Heart Teams when treating young patients with severe symptomatic aortic stenosis with either TAVR or iSAVR and to identify the relevant considerations. Out of the considered factors, the variables most prominently featured in our ML model were congestive heart failure, established risk assessment scores, previous cardiac surgeries, a reduced left ventricular ejection fraction and peripheral vascular disease. Our study demonstrates a viable application of ML-based approaches for studying and understanding complex clinical decision-making processes.

Citing Articles

The role of artificial intelligence in aortic valve stenosis: a bibliometric analysis.

Chen S, Wu C, Zhang Z, Liu L, Zhu Y, Hu D Front Cardiovasc Med. 2025; 12:1521464.

PMID: 40013126 PMC: 11860872. DOI: 10.3389/fcvm.2025.1521464.


Artificial Intelligence in Transcatheter Aortic Valve Replacement: Its Current Role and Ongoing Challenges.

Benjamin M, Rabbat M Diagnostics (Basel). 2024; 14(3).

PMID: 38337777 PMC: 10855497. DOI: 10.3390/diagnostics14030261.


Automated data preparation for tumor characterization with machine learning.

Krajnc D, Spielvogel C, Grahovac M, Ecsedi B, Rasul S, Poetsch N Front Oncol. 2022; 12:1017911.

PMID: 36303841 PMC: 9595446. DOI: 10.3389/fonc.2022.1017911.

References
1.
Sidey-Gibbons J, Sidey-Gibbons C . Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019; 19(1):64. PMC: 6425557. DOI: 10.1186/s12874-019-0681-4. View

2.
Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View

3.
Otto C, Nishimura R, Bonow R, Carabello B, Erwin 3rd J, Gentile F . 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 143(5):e72-e227. DOI: 10.1161/CIR.0000000000000923. View

4.
Kamperidis V, Delgado V, Van Mieghem N, Kappetein A, Leon M, Bax J . Diagnosis and management of aortic valve stenosis in patients with heart failure. Eur J Heart Fail. 2016; 18(5):469-81. DOI: 10.1002/ejhf.466. View

5.
Voigtlander L, Seiffert M . Expanding TAVI to Low and Intermediate Risk Patients. Front Cardiovasc Med. 2018; 5:92. PMC: 6052659. DOI: 10.3389/fcvm.2018.00092. View